Introduction
Ayurveda is a traditional system of medicine recognized for its holistic approach to health and disease management. The term Ayurveda is derived from Sanskrit, meaning “science of life,” and is considered one of the oldest healthcare systems, originating in India over 5,000 years ago. Its primary objective is to maintain health, prevent disease, and restore physiological balance by harmonizing the individual with nature.
In the present era, rapid urbanization, sedentary behavior, and altered dietary patterns have significantly contributed to the rise of lifestyle-related disorders. These conditions are broadly correlated with Santarpanajanya Vyadhi in Ayurveda, characterized by excessive nourishment leading to Kapha aggravation and Meda Dhatu accumulation. Contemporary medicine identifies similar patterns in metabolic syndrome and related chronic diseases, although long-term curative options remain limited and often dependent on pharmacological management.
In this context, Ayurveda offers preventive and therapeutic strategies that emphasize early intervention through dietary regulation, lifestyle modification, and herbal interventions, thereby addressing disease at its root cause and potentially reducing complications.
Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent metabolic liver disorders globally. It is characterized by excessive fat accumulation in hepatocytes, ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), which may progress to fibrosis, cirrhosis, and hepatocellular carcinoma. The increasing prevalence of obesity, insulin resistance, and dyslipidemia has made NAFLD a significant public health concern, closely linked to modern lifestyle transitions.1
Role of Ahara Parivarjana
Conceptual basis of Ahara Parivarjana in Ayurveda:
Ayurveda considers Ahara (diet) as the primary determinant of health and disease, as stated in the principle “Ahara Sambhavam Vastu”. In Non-alcoholic fatty liver disease (NAFLD), improper dietary habits are key etiological factors. Ahara Parivarjana refers to the systematic avoidance of pathogenic foods and adoption of wholesome dietary practices to restore Agni, reduce Ama, and balance Kapha–Pitta, thereby improving hepatic metabolism and reducing Meda Dhatu accumulation.
Ahara hetu (dietary etiological factors in NAFLD)
Unhealthy dietary practices contributing to NAFLD include:
- Excess intake of fatty and fried foods (Ati Sneha)
- High sugar and refined carbohydrate consumption (Ati Madhura)
- Heavy and channel-obstructing foods (Guru, Abhishyandi Ahara)
- Incompatible food combinations (Viruddha Ahara)
- Irregular eating patterns (Adhyashana)
- Daytime sleep and sedentary lifestyle (Divaswapna, Alasyata)
These factors lead to Agnimandya, Ama formation, and Srotorodha, corresponding to insulin resistance, dyslipidemia, and hepatic fat accumulation in modern terms.
Pathya ahara (recommended diet in NAFLD)
Diet in NAFLD should be light, digestible, and Kapha–Pitta pacifying, with emphasis on Tikta, Kashaya, and Katu rasa.
Recommended foods:
- Cereals: barley, millets, red rice
- Pulses: green gram, horse gram
- Vegetables: bitter gourd, bottle gourd, ridge gourd, drumstick
- Fruits: amla, pomegranate, papaya
- Spices: turmeric, ginger, black pepper, cumin
- Fluids: buttermilk, warm water, herbal decoctions (Triphala, Guduchi)
- Fats: minimal use of sesame or flaxseed oil
These foods enhance digestion, reduce fat deposition, and support hepatic function.
Apathya Ahara (Foods to be avoided in NAFLD)
|
Food type |
Examples |
Effect on liver / metabolism |
|
Heavy and oily foods |
Fried items, cheese, butter, excess ghee |
Promotes Kapha–Meda accumulation and hepatic fat deposition |
|
Sweet and refined carbohydrates |
Sugar, bakery products, sweets, polished rice |
Contributes to Meda Vriddhi, insulin resistance, and lipogenesis |
|
Fermented and incompatible foods |
Curd at night, milk with sour fruits |
Increases Ama formation and Srotorodha (metabolic channel obstruction) |
|
Cold and carbonated beverages |
Ice creams, cold drinks, aerated beverages |
Suppresses Agni and impairs hepatic metabolic activity |
|
Red meat and processed foods |
Sausages, preserved meat, junk foods |
Enhances oxidative stress and hepatic inflammation |
|
Sedentary lifestyle and day sleep |
Prolonged sitting, lack of exercise, daytime sleep |
Aggravates Kapha, reduces metabolic rate, and promotes fat accumulation |
Pathya vihara (dietary and lifestyle discipline)
- Timely meals (Kāla Bhojana)
- Moderate food intake (Mātrā)
- Mindful eating without distraction
- Avoidance of late-night heavy meals
- Regular light exercise (walking, yoga, Surya Namaskara)
- Avoidance of daytime sleep
These measures improve metabolic regulation and prevent further hepatic fat accumulation.
Modern nutritional correlation
Modern evidence supports Ayurvedic dietary principles:
- Caloric restriction improves liver enzymes and steatosis
- High-fiber diets reduce insulin resistance
- Antioxidant-rich foods reduce oxidative stress
- Intermittent fasting improves hepatic fat oxidation
- Probiotic-rich foods (e.g., buttermilk) support gut–liver axis
Thus, Ahara Parivarjana aligns with contemporary evidence-based dietary therapy for NAFLD.
Role in post-Panchakarma phase
After detoxification, Samsarjana Krama gradually restores digestive capacity through a stepwise diet (Manda → Peya → Vilepi → Laghu Ahara). This prevents metabolic overload and supports hepatic recovery, similar to structured refeeding protocols in modern hepatology.
Conclusion
Ahara Parivarjana is a foundational therapeutic strategy in NAFLD that addresses disease at its root by correcting dietary causes, restoring metabolic balance, and complementing both Ayurvedic and modern hepatoprotective approaches.2
References:
- Panjeta N. NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS MANAGEMENT- A CRITICAL REVIEW. wjpmr, 2025, 11(6), 4-11. https://www.wjpmr.com/download/article/135052025/1748685146.pdf
- Sahu P, Zala M, Saini N, Koodur S, Singh T. Role of Panchakarma and Ahara Parivarjana in Non-Alcoholic Fatty Liver Disease (Yakrit Roga). J Ayu Int Med Sci. 2026;11(2):281-291. DOI:10.21760/jaims.11.2.44. https://jaims.in/jaims/article/download/5440/9906?inline=1